Exploring the necessity of molecular detection for Streptococcus dysgalactiae subsp equisimilis: Often misdiagnosed, and emerging pathogen

Background

Streptococcus dysgalactiae subsp equisimilis (SDSE) is an emerging pathogen causing pharyngitis and post-streptococcal sequelae like S. pyogenes. SDSE was initially considered a commensal microorganism inhabiting the upper respiratory tract and skin. However, recently it has gained attention due to an increase in the invasive SDSE infections, which were reported in the early 20th century.

Objectives

The aim of this review is to bring awareness of SDSE in the medical microbiologists because often its ignorance leads to the under reporting or misdiagnosis of SDSE. This also highlights the clinical spectrum of infections and the molecular epidemiology of SDSE.

Content

Diagnosis of SDSE in clinical laboratories is challenging, because SDSE can be seen expressing either of the three Lancefield antigen Groups, Group A, C, and G. While MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization Time-of-Flight) is a discriminatory method for identifying SDSE, its high cost can limit its use in many laboratories. Currently, there is limited data on SDSE, and further studies are required to associate the disease outcome and the emm type/ST of SDSE in India and other developing countries. This review highlights the importance of recognizing SDSE as an emerging pathogen, and to screen for SDSE in infections similar to S.pyogenes, especially in regions such as India with a high incidence of Streptococcal diseases.